Search results
Showing 2581 to 2595 of 8998 results
Durvalumab (Imfinzi) +/- bevacizumab (Avastin) for hepatocellular carcinoma [TSID10736]
Awaiting development Reference number: GID-TA11076 Expected publication date: TBC
Tislelizumab for untreated unresectable hepatocellular carcinoma [TSID10683]
Awaiting development Reference number: GID-TA11053 Expected publication date: TBC
Plinabulin with docetaxel for previously treated advanced non-small-cell lung cancer [ID3895]
Awaiting development Reference number: GID-TA10776 Expected publication date: TBC
Avelumab for untreated PD-L1 positive recurrent or metastatic non-small-cell lung cancer [ID1261]
In development Reference number: GID-TA10250 Expected publication date: TBC
Doxorubicin nanoparticles for previously treated advanced hepatocellular carcinoma [ID1314]
In development Reference number: GID-TA10251 Expected publication date: TBC
In development Reference number: GID-TA10248 Expected publication date: TBC
Awaiting development Reference number: GID-TA11932 Expected publication date: TBC
Topic prioritisation
MRI guided transurethral high intensity ultrasound ablation of the prostate
Topic prioritisation
Coronary venous arterialisation in patients with refractory angina
Topic prioritisation
EchoLaser percutaneous laser ablation treatment for patients with neck lesions
Topic prioritisation
Topic prioritisation